Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

Add To Watchlist

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Though forward …??

View:

Post by canadafan on Nov 03, 2024 2:27pm

Though forward …??

So far, no update or nR regarding Q3 results
usually out by now.

could mean something of interest? Or just internal delays
They do have until Nov29.
My wish?
they are in buyout negotiations & holding off
Only a wish. Very possible,
look forward to that announcement.

either way, lots up soon. Thd IRENE study update. Poster.
Q3
snd ..., how to find the Mbc 2025 product trial & pending accelerated approval!

230

Comment

Comment by Quentin30 on Nov 05, 2024 3:41pm

I think you mean "fund" the mBC product trial... and just to be clear accelerated approval is a MINIMUM of 2 years away... It may be accelerated approval by definition, but by the time it is granted, IF it is granted, 10 years will have elapsed since ONCY was granted a SPA to run a final phase III trial.. Where is Matt he's been missing in action for over 4 months now....

Comment

Oncolytics Biotech Inc